Home Tags Enhertu

Tag: Enhertu

Doctor discussing treatment options with a patient.

FDA Approves First Diagnostic Tests to Identify HER2-positive Metastatic Breast Cancer...

Editorial Team -

ESMO 2025: A New Generation of Antibody-drug Conjugates Demonstrates Unprecedented Promise...

Editorial Team -

ASCO 2025: DESTINY-Gastric04 Shows that Trastuzumab Deruxtecan Reduces the Risk of...

Editorial Team -

Japan Approves Datopotamab Deruxtecan for the Treatment of Adult Patients with...

Peter Hofland -

DNADX® Test Significantly Correlates with Patient Outcomes in Clinical Studies

Editorial Team -

Trastuzumab Deruxtecan Is an Effective Option for Difficult-to-treat HER2-expressing Solid Tumors

Editorial Team -

Novel ADC Doubles Progression-Free Survival in Metastatic Breast Cancer with Low...

Danielle Garcia -

First patient Dosed with Trastuzumab Deruxtecan in DESTINY-Breast09 Trial

Editorial Team -

Trastuzumab deruxtecan Granted Priority Review in HER2 Positive Metastatic Gastric Cancer

Peter Hofland -
A doctor examines mammogram snapshot of breast of patient on the monitors.

Trastuzumab deruxtecan Launched in Japan for HER2+ Unresectable or Metastatic Breast...

Editorial Team -
12Page 1 of 2

LATEST NEWS